ES2072387T3 - Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta. - Google Patents

Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.

Info

Publication number
ES2072387T3
ES2072387T3 ES90302374T ES90302374T ES2072387T3 ES 2072387 T3 ES2072387 T3 ES 2072387T3 ES 90302374 T ES90302374 T ES 90302374T ES 90302374 T ES90302374 T ES 90302374T ES 2072387 T3 ES2072387 T3 ES 2072387T3
Authority
ES
Spain
Prior art keywords
octane
methoxy
thrombus
medication
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90302374T
Other languages
English (en)
Inventor
Kengo Akimoto
Yoshifumi Shinmen
Hideaki Yamada
Sakayu Shimizu
Michihiro Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2072387T3 publication Critical patent/ES2072387T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA COMPOSICION PARA INHIBIR DESATURASA-D5 QUE COMPRENDE UN INGREDIENTE EFECTIVO SELECCIONADO DEL GRUPO QUE CONSTA DE COMPONENTES LIGNAN, CURCUMIN Y BUTOXIDO PIPERONIL. COMO LOS COMPONENTES LIGNAN SESAMIN, SESAMINOL, EPISESAMIN, EPISESAMINOL, SESAMOLIN, OCTANO[3.3.0]DIOXABICICLO-3,7-(HIDROXIFENIL-4-METOXI-3)-6-(METILENODIOXIFENIL3,4)-2, OCTANO[3.3.0]DIOXABICICLO-3,7-(HIDROXIFENIL-4-METOXI-3)-BIS-2,6, Y OCTANO[3.3.0]DIOXABICICLO-3,7-(HIDROXIFENOXI-4-METOXI-3)-6-(METILENODIOXIFENIL -3,4)-2. ADEMAS EL INGREDIENTE EFECTIVO DEBE SER UN EXTRACTO DE ACEITE DE SESAMO O EXTRACTO DE SEMILLA DE SESAMO.
ES90302374T 1989-03-07 1990-03-06 Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta. Expired - Lifetime ES2072387T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5295089 1989-03-07
JP2020469A JP3070611B2 (ja) 1989-03-07 1990-02-01 △▲上５▼―不飽和化酵素阻害剤

Publications (1)

Publication Number Publication Date
ES2072387T3 true ES2072387T3 (es) 1995-07-16

Family

ID=26357435

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90302374T Expired - Lifetime ES2072387T3 (es) 1989-03-07 1990-03-06 Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.

Country Status (6)

Country Link
US (1) US5336496A (es)
EP (1) EP0387000B1 (es)
JP (1) JP3070611B2 (es)
AT (1) ATE122884T1 (es)
DE (1) DE69019565T2 (es)
ES (1) ES2072387T3 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034181T2 (de) * 1989-07-21 2006-01-26 Suntory Ltd. Kapsel, enthaltend ein Dioxabicyclo(3.3.0)oktan
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06227977A (ja) * 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
US5606035A (en) * 1994-01-25 1997-02-25 Kawakishi; Shunrou Sesaminol glucosides
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
KR970705345A (ko) * 1995-07-04 1997-10-09 도리이 신이치로 오메가 6계ㆍ오메가 3계 불포화 지방산의 밸런스 조절제를 배합하여 이루어진 식품 조성물(Food composition containing balancing agent for ω- 6 and ω- 3 unsaturated fatty acids)
US5811313A (en) * 1997-06-17 1998-09-22 King Pharmaceuticals, Inc. Identification test for highly refined sesame oil
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
WO2001062954A2 (en) * 2000-02-24 2001-08-30 Xenon Genetics, Inc. Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
US20030064950A1 (en) * 2001-02-23 2003-04-03 Ntambi James M. Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity
ATE402262T1 (de) * 2000-09-26 2008-08-15 Xenon Pharmaceuticals Inc Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
AU2002218091A1 (en) * 2000-11-17 2002-05-27 Xenon Genetics Inc Fat regulated genes, uses thereof, and compounds for modulating same
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
JP2005500857A (ja) * 2001-08-29 2005-01-13 ゼノン ジェネティクス，インコーポレイテッド 脂肪酸合成酵素を用いたハイスループットスクリーニング分析
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
JP5384777B2 (ja) * 2001-12-18 2014-01-08 有限会社大長企画 強筋肉剤、抗炎症剤
FI114917B (fi) * 2002-08-29 2005-01-31 Hormos Nutraceutical Oy Ltd Lignaanikomplekseja
US6958146B2 (en) * 2003-05-28 2005-10-25 Bug Buster Ltd. Compounds to affect insect behavior and to enhance insecticides
US7867479B2 (en) * 2003-11-14 2011-01-11 Bug Buster, Ltd. Compounds to affect insect behavior and/or bird behavior
ES2375115T3 (es) * 2005-03-31 2012-02-24 Suntory Holdings Limited Emulsión de aceite en agua que contiene un compuesto de lignano y composición que comprenden al mismo.
EP1930333B1 (en) 2005-09-30 2014-11-05 Suntory Holdings Limited Method and apparatus for producing episesamin-rich composition
JP4876637B2 (ja) * 2006-03-08 2012-02-15 パナソニック株式会社 除湿装置
EP2002832A4 (en) 2006-03-31 2009-11-11 Suntory Holdings Ltd COMPOSITION WITH A LIGNAN CONNECTION
US20080194557A1 (en) * 2007-01-18 2008-08-14 Joseph Barbosa Methods and compositions for the treatment of pain, inflammation and cancer
WO2008089310A2 (en) * 2007-01-18 2008-07-24 Lexicon Pharmaceuticals, Inc. Delta 5 desaturase inhibitors for the treatment of obesity
DE112008000860B4 (de) 2007-03-30 2016-07-28 Council Of Scientific And Industrial Research Verfahren für die Extraktion von bioaktiven Lignanen aus Sesamöl mit hoher Ausbeute und Reinheit
AU2008246396A1 (en) * 2007-05-04 2008-11-13 Eva Brannas Compound feed for aquaculture
SG10201510301UA (en) 2007-09-19 2016-01-28 Suntory Holdings Ltd Compositions incorporating sesamin-class compounds and vitamin b1 class compounds
EP3733857A3 (en) * 2013-12-04 2020-12-09 Nippon Suisan Kaisha, Ltd. Dihomo-gamma-linolenic acid-containing microbial oil and dihomo-gamma-linolenic acid-containing microbial biomass
KR101641002B1 (ko) * 2014-12-31 2016-07-19 박상은 철핀장치를 구비한 스노우타이어
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US113713A (en) * 1871-04-11 Improvement in medical compounds or bitters
US1518365A (en) * 1923-06-23 1924-12-09 Shahapzian Nazik Ointment
US4044118A (en) * 1974-05-16 1977-08-23 Texaco Inc. Solubilizing process for oil insoluble pesticides
US4103006A (en) * 1976-05-20 1978-07-25 Wisconsin Alumni Research Foundation Glycosides of 2,6-bis(hydroxy-phenyl)-3,7-dioxabicyclo [3,3,0] octane
US4083970A (en) * 1976-12-10 1978-04-11 Stauffer Chemical Company Activated insecticide composition employing a certain phosphorodithioate and an activator
US4427694A (en) 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
FR2574089B1 (fr) * 1984-12-03 1987-04-10 Inst Nat Sante Rech Med Procede de production d'acides gras, en particulier d'acide g-linoleique a partir de tetrahymena, produits obtenus et preparation medicamenteuse ou alimentaire contenant de l'acide g-linolenique ou ses derives en tant qu'agent anti-agregation plaquettaire
JPS6330416A (ja) * 1986-07-24 1988-02-09 Wakunaga Pharmaceut Co Ltd 脳循環代謝改善剤
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
JP2746371B2 (ja) * 1987-12-21 1998-05-06 サントリー株式会社 ビスホモ−γ−リノレン酸及びこれを含有する脂質の製造方法
US5093249A (en) * 1989-05-24 1992-03-03 Idemitsu Petrochemical Co., Ltd. Process for production of dihomo-γ-linolenic acid and inhibitor for unsaturation reaction at Δ5-position of fatty acid

Also Published As

Publication number Publication date
DE69019565T2 (de) 1995-09-28
ATE122884T1 (de) 1995-06-15
EP0387000A2 (en) 1990-09-12
DE69019565D1 (de) 1995-06-29
US5336496A (en) 1994-08-09
JPH0327319A (ja) 1991-02-05
EP0387000A3 (en) 1991-08-07
EP0387000B1 (en) 1995-05-24
JP3070611B2 (ja) 2000-07-31

Similar Documents

Publication Publication Date Title
ES2072387T3 (es) Medicamento para el tratamiento de trombo, inflamacion y presion sanguinea alta.
DE69033848D1 (de) Mittel zur Verbesserung der Leberfunktion
EP0419653A4 (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
ITMI950493A0 (it) Frazioni polifenoliche di te' loro uso e formulazioni che le contengono
FI841508A0 (fi) Delbar tablett med foerdroejd frigivning av aktivaemne och foerfarande foer dess framstaellning.
ATE212860T1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
MX9202300A (es) Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
FR2712288B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
EP0681788A3 (en) Dioxabicyclo[3.3.0] octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
FR2651230B1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et applications comme medicaments.
MX9207070A (es) Compuestos de benzofurano, procedimiento para su preparacion y preparado farmaceutico que los contiene.
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
IT8920292A0 (it) Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.
FR2711370B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
MX9202280A (es) Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT1240348B (it) Procedimento ed apparecchiatura per la produzione di contenitori e oggetti sterili in genere, particolarmente per uso farmaceutico
FR2710642B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
MX23342A (es) Procedimiento para la preparacion de compuestos azabiciclicos, producto obtenido y composicion farmaceutica que lo incluye.
MX23331A (es) Proceso para la preparacion de derivados de benzopirano, isomero obtenido y composicion farmaceutica que lo incluye.
IT8921608A0 (it) Composizioni a base di tessuti vegetali od animali e procedimento per la loro preparazione.
MX14229A (es) Procedimiento para la preparaciion de compuestos triciclicos y producto obtenido.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387000

Country of ref document: ES